bioMérieux announces CE-marking of VIDAS® KUBE™, the next generation system in the VIDAS® immunoassay portfolio

20 Dec 2022 18:00 CET

Issuer

BIOMERIEUX

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1127459_PR_bioMerieux_VIDAS_Kube_20221220.pdf

Source

BIOMERIEUX

Provider

Les Echos

Company Name

BIOMERIEUX

ISIN

FR0013280286

Symbol

BIM

Market

Euronext